SERUM MONITORING OF TEICOPLANIN

被引:21
作者
MACGOWAN, AP [1 ]
MCMULLIN, CM [1 ]
WHITE, LO [1 ]
REEVES, DS [1 ]
DAVIS, E [1 ]
SPELLER, DCE [1 ]
机构
[1] SOUTHMEAD GEN HOSP, DEPT MED MICROBIOL, BRISTOL BS10 5NB, AVON, ENGLAND
关键词
D O I
10.1093/jac/30.3.399-a
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:399 / 401
页数:3
相关论文
共 11 条
[1]   EARLY TERMINATION OF A PROSPECTIVE, RANDOMIZED TRIAL COMPARING TEICOPLANIN AND FLUCLOXACILLIN FOR TREATING SEVERE STAPHYLOCOCCAL INFECTIONS [J].
CALAIN, P ;
KRAUSE, KH ;
VAUDAUX, P ;
AUCKENTHALER, R ;
LEW, D ;
WALDVOGEL, F ;
HIRSCHEL, B .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (02) :187-191
[2]   EFFECTS OF DOSAGE, PEAK AND TROUGH CONCENTRATIONS IN SERUM, PROTEIN-BINDING, AND BACTERICIDAL RATE ON EFFICACY OF TEICOPLANIN IN A RABBIT MODEL OF ENDOCARDITIS [J].
CHAMBERS, HF ;
KENNEDY, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) :510-514
[3]   POOR EFFICACY OF TEICOPLANIN IN TREATMENT OF DEEP-SEATED STAPHYLOCOCCAL INFECTIONS [J].
GALANAKIS, N ;
GIAMARELLOU, H ;
VLACHOGIANNIS, N ;
DENDRINOS, C ;
DAIKOS, GK .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (02) :130-134
[4]   FAILURE OF TREATMENT WITH TEICOPLANIN AT 6 MILLIGRAMS KILOGRAM DAY IN PATIENTS WITH STAPHYLOCOCCUS-AUREUS INTRAVASCULAR INFECTION [J].
GILBERT, DN ;
WOOD, CA ;
KIMBROUGH, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) :79-87
[5]   CLINICAL-EVALUATION OF TEICOPLANIN FOR THERAPY OF SEVERE INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA [J].
GLUPCZYNSKI, Y ;
LAGAST, H ;
VANDERAUWERA, P ;
THYS, JP ;
CROKAERT, F ;
YOURASSOWSKY, E ;
MEUNIERCARPENTIER, F ;
KLASTERSKY, J ;
KAINS, JP ;
SERRUYSSCHOUTENS, E ;
LEGRAND, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) :52-57
[6]   TEICOPLANIN IN COMBINATION THERAPY FOR FEBRILE EPISODES IN NEUTROPENIC AND NON-NEUTROPENIC PEDIATRIC-PATIENTS [J].
LEMERLE, S ;
DELAROCQUE, F ;
LAMY, R ;
FREMAUX, A ;
BERNAUDIN, F ;
LOBUT, JB ;
REINERT, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 :113-116
[7]   EVALUATION OF TEICOPLANIN FOR TREATMENT OF ENDOCARDITIS CAUSED BY GRAM-POSITIVE COCCI IN 20 PATIENTS [J].
LEPORT, C ;
PERRONNE, C ;
MASSIP, P ;
CANTON, P ;
LECLERCQ, P ;
BERNARD, E ;
LUTUN, P ;
GARAUD, JJ ;
VILDE, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :871-876
[8]   A MULTICENTER OPEN CLINICAL-TRIAL OF TEICOPLANIN IN INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA [J].
LEWIS, P ;
GARAUD, JJ ;
PARENTI, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 :61-67
[9]   CLINICAL PHARMACOKINETICS OF TEICOPLANIN [J].
ROWLAND, M .
CLINICAL PHARMACOKINETICS, 1990, 18 (03) :184-209
[10]   TEICOPLANIN PHARMACOKINETICS IN INTRAVENOUS DRUG-ABUSERS BEING TREATED FOR BACTERIAL-ENDOCARDITIS [J].
RYBAK, MJ ;
LERNER, SA ;
LEVINE, DP ;
ALBRECHT, LM ;
MCNEIL, PL ;
THOMPSON, GA ;
KENNY, MT ;
YUH, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :696-700